WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ADMA

Based on 3 analysts offering 12 month price targets for Adma Biologics Inc.
Min Forecast
$5.00+39.28%
Avg Forecast
$5.67+57.86%
Max Forecast
$6.00+67.13%

Should I buy or sell ADMA stock?

Based on 3 analysts offering ratings for Adma Biologics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ADMA stock forecasts and price targets.

ADMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Top 3%
98
Strong BuyMaintains$6.00+67.13%2023-08-10
Raymond James
Bottom 7%
7
Strong BuyMaintains$6.00+67.13%2023-08-10
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$5.00+39.28%2023-08-10

1 of 1

Forecast return on equity

Is ADMA forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.73%

Forecast return on assets

Is ADMA forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.11%

ADMA revenue growth forecast

How is ADMA forecast to perform vs Biotechnology companies and vs the US market?
Company
9.72%
Industry
34.63%
Market
8.12%
ADMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ADMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ADMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADMA$3.59$5.67+57.86%Strong Buy
VALN$11.61$22.00+89.49%Buy
VERV$12.63$34.40+172.37%Buy
ADPT$5.64$13.50+139.36%Buy
KYMR$14.75$49.83+237.85%Buy
View Top Biotech Stocks

Adma Biologics Stock Forecast FAQ

Is Adma Biologics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ADMA) stock is to Strong Buy ADMA stock.

Out of 3 analysts, 2 (66.67%) are recommending ADMA as a Strong Buy, 1 (33.33%) are recommending ADMA as a Buy, 0 (0%) are recommending ADMA as a Hold, 0 (0%) are recommending ADMA as a Sell, and 0 (0%) are recommending ADMA as a Strong Sell.

If you're new to stock investing, here's how to buy Adma Biologics stock.

What is ADMA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.

What is ADMA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ADMA price target, the average ADMA price target is $5.67, with the highest ADMA stock price forecast at $6.00 and the lowest ADMA stock price forecast at $5.00.

On average, Wall Street analysts predict that Adma Biologics's share price could reach $5.67 by Aug 10, 2024. The average Adma Biologics stock price prediction forecasts a potential upside of 57.86% from the current ADMA share price of $3.59.

What is ADMA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ADMA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.